These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12970023)

  • 1. A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
    Taniguchi Y; Ueshima K; Chiba I; Segawa I; Kobayashi N; Saito M; Hiramori K
    Chest; 2003 Sep; 124(3):954-61. PubMed ID: 12970023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of beta-blockade with metoprolol on symptoms and functional capacity of patients with idiopathic dilated cardiomyopathy.
    Santostasi G; Marinato PG; Miraglia G; Egloff C; Maragno I
    Minerva Cardioangiol; 1994 Dec; 42(12):575-82. PubMed ID: 7753426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy.
    Waagstein F; Strömblad O; Andersson B; Böhm M; Darius M; Delius W; Goss F; Osterziel KJ; Sigmund M; Trenkwalder SP; Wahlqvist I
    Eur J Heart Fail; 2003 Oct; 5(5):679-91. PubMed ID: 14607208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockade and exercise capacity in patients with mitral stenosis in sinus rhythm.
    Monmeneu Menadas JV; Marín Ortuño F; Reyes Gomis F; Jordán Torrent A; García Martínez M; Bodí Peris V; García de Burgos de Rico E
    J Heart Valve Dis; 2002 Mar; 11(2):199-203. PubMed ID: 12000160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study.
    Patrianakos AP; Parthenakis FI; Mavrakis HE; Saatsaki M; Diakakis GF; Chlouverakis GI; Vardas PE
    Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group.
    DiLenarda A; Gregori D; Sinagra G; Lardieri G; Perkan A; Pinamonti B; Salvatore L; Secoli G; Zecchin M; Camerini F
    J Card Fail; 1996 Jun; 2(2):87-102. PubMed ID: 8798110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated cardiomyopathy.
    Clements IP; Miller WL
    Am Heart J; 2001 Feb; 141(2):259. PubMed ID: 11174349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G; Perkan A; Di Lenarda A; Lardieri G; Pinamonti B; Mestroni L; Miani D; Camerini F
    G Ital Cardiol; 1992 Aug; 22(8):969-89. PubMed ID: 1362167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study.
    Circulation; 2000 Feb; 101(4):378-84. PubMed ID: 10653828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy.
    Suwa M; Ito T; Otake Y; Moriguchi A; Hirota Y; Kawamura K
    Jpn Circ J; 1996 Oct; 60(10):767-73. PubMed ID: 8933239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-blockers in left ventricular dysfunction and heart failure.
    Hjalmarson A; Kneider M; Waagstein F
    Drugs; 1997 Oct; 54(4):501-10. PubMed ID: 9339958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of cardiopulmonary exercise test in cardiac function evaluation of patients with chronic left heart failure caused by dilated cardiomyopathy].
    Zhang W; Huang J; Xu H; Zhang S; Liu Z; Liao Z; Ma X; Liu Q
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(14):1076-9. PubMed ID: 24851891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term beta-blockade therapy in patients with dilated cardiomyopathy--serial clinical and echocardiographic observations.
    Yokota Y; Nomura H; Kawai H; Fukuzaki H
    Jpn Circ J; 1992 Jan; 56(1):52-61. PubMed ID: 1538576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing.
    Genth-Zotz S; Zotz RJ; Sigmund M; Hanrath P; Hartmann D; Böhm M; Waagstein F; Treese N; Meyer J; Darius H
    Eur J Heart Fail; 2000 Jun; 2(2):175-81. PubMed ID: 10856731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure.
    Santostasi G; Fraccarollo D; Dorigo P; Egloff C; Miraglia G; Marinato PG; Villanova C; Fasoli G; Maragno I
    J Card Fail; 1998 Sep; 4(3):177-84. PubMed ID: 9754588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilated cardiomyopathy with hypertension: prevalence and response to high-dose β1-adrenoceptor antagonist therapy.
    Zheng X; Chen S; Wang J; Yang T; Chen Y
    Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):945-9. PubMed ID: 19473337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
    Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
    J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.